Correlation Between Neurocrine Biosciences and Adial Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Adial Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Adial Pharmaceuticals.
Diversification Opportunities for Neurocrine Biosciences and Adial Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neurocrine and Adial is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Adial Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Adial Pharmaceuticals
Given the investment horizon of 90 days Neurocrine Biosciences is expected to under-perform the Adial Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Neurocrine Biosciences is 1.48 times less risky than Adial Pharmaceuticals. The stock trades about -0.3 of its potential returns per unit of risk. The Adial Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 78.00 in Adial Pharmaceuticals on December 6, 2024 and sell it today you would lose (2.64) from holding Adial Pharmaceuticals or give up 3.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Adial Pharmaceuticals
Performance |
| Timeline |
| Neurocrine Biosciences |
| Adial Pharmaceuticals |
Neurocrine Biosciences and Adial Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Adial Pharmaceuticals
The main advantage of trading using opposite Neurocrine Biosciences and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |